Target intelligence / Profile preview

Multiple cellular and tissue microenvironment components (TME)

Target
TME
Molecular classification
Other
01

Overview

The term 'Multiple cellular and tissue microenvironment components' refers to the complex and dynamic ecosystem surrounding a specific tissue or tumor, commonly known as the tumor microenvironment (TME) [1]. This environment is composed of various cellular entities, including immune cells, fibroblasts, and endothelial cells, as well as non-cellular components like the extracellular matrix (ECM) and signaling molecules such as cytokines [2]. These components interact to regulate essential biological processes like angiogenesis, immune evasion, and metabolic reprogramming, which are often hijacked in diseases like cancer to promote survival and metastasis [3]. While many therapeutic agents target specific molecules within this system—such as PD-1 on T-cells or VEGF in the stroma—the microenvironment itself is a multi-component system rather than a single molecular target [4]. Consequently, this entry is considered 'incorrect' as a single target because it encompasses a vast array of distinct biological entities that require specific, individual characterization for drug development [5]. [1] https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-microenvironment [2] https://doi.org/10.1016/j.cub.2020.01.030 [3] https://www.nature.com/articles/s41591-018-0014-x [4] https://doi.org/10.1016/j.pharmthera.2020.107753 [5] https://doi.org/10.1186/s12964-020-0530-4

Other names
Tumor microenvironmentTissue microenvironmentStromaExtracellular matrixTumor niche
02

Mechanism of action

Modulation of the cellular and extracellular components of the tissue environment to inhibit disease progression or enhance therapeutic response.

03

Biological functions

Immune responseAngiogenesisSignal transductionCell proliferationStructural support
04

Disease associations

CancerInflammationFibrosisCardiovascular disease
05

Safety considerations

Systemic immune-related adverse events (irAEs)Off-target effects on healthy tissue architectureCytokine release syndromeImpaired wound healing
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

PD-L1 expressionTumor-infiltrating lymphocytes (TILs)Cancer-associated fibroblasts (CAFs)Vascular endothelial growth factor (VEGF) levels

Beyond the preview

Go deeper on Multiple cellular and tissue microenvironment components (TME).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple cellular and tissue microenvironment components (TME).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call